SEC Form 4
FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
| 2. Issuer Name and Ticker or Trading Symbol HANGER, INC. [ HNGR ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| ||||||||||||||||||||||||
3. Date of Earliest Transaction (Month/Day/Year) 02/15/2022 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 02/15/2022 | A(1) | 66,439 | A | $0 | 819,758(2)(3)(4)(5)(6)(7) | D |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Options (right to buy) | $12.77 | (8) | 05/19/2027 | Common Stock | 159,982 | 159,982 | D |
Explanation of Responses: |
1. Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2021 and ending on December 31, 2021. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date. |
2. Includes (i) unvested restricted shares totaling 66,439 shares of stock from an initial grant of 66,439 shares of restricted stock which begins to vest on March 8, 2022; (ii) unvested restricted shares totaling 55,791 shares of stock from an initial grant of 55,791 shares of restricted stock which begins to vest on March, 8, 2022; (iii) unvested restricted shares totaling 62,847 shares of stock from an initial grant of 69,705 shares of restricted stock which begins to vest on March 9, 2021; (iv) unvested restricted shares totaling 49,292 shares of stock from an initial grant of 54,670 shares of restricted stock which begins to vest on March 9, 2021; [continued in next footnote] |
3. (v) unvested restricted shares and fully vested shares totaling 59,429 shares of stock from an initial grant of 73,987 shares of restricted stock made on March 8, 2019; (vi) unvested restricted shares and fully vested shares totaling 46,954 shares of stock from an initial grant of 58,456 shares of restricted stock made on March 8, 2019; (vii) unvested restricted shares and fully vested shares totaling 56,786 shares of stock from an initial grant of 80,564 shares of restricted stock made on March 9, 2018; (viii) unvested restricted shares and fully vested shares totaling 57,312 shares of stock from an initial grant of 94,500 shares of restricted stock, 25% of which vested on May 17, 2018 and the remainder of which vested on March 8, 2019, 2020 and 2021; [continued in next footnote] |
4. (ix) unvested restricted shares and fully vested shares totaling 38,188 shares of stock from an initial grant of 60,000 shares of restricted stock made on April 29, 2016; (x) unvested restricted shares and fully vested shares totaling 47,590 shares of stock from an initial grant of 67,516 shares of restricted stock made on March 9, 2018; (xi) fully vested shares totaling 65,566 shares of stock from an initial grant of 95,376 shares of restricted stock made on March 6, 2015; (xii) unvested restricted shares and fully vested shares totaling 36,388 shares of stock from an initial grant of 60,000 shares of restricted stock made on March 8, 2017; [continued in next footnote] |
5. (xiii) fully vested shares totaling 32,807 shares of stock from an initial grant of 42,390 shares of restricted stock made on March 6, 2015; (xiv) fully vested shares totaling 13,746 shares of stock from an initial grant of 17,973 shares of restricted stock made on March 7, 2014; (xv) fully vested shares totaling 17,963 shares of stock from an initial grant of 29,292 shares of restricted stock and performance shares made on March 11, 2013; (xvi) fully vested shares totaling 9,917 shares of stock from an initial grant of 17,250 shares of restricted stock and performance shares made on August 27, 2012; [continued in next footnote] |
6. (xvii) fully vested shares totaling 15,868 shares of stock from an initial grant of 27,600 shares of restricted stock and performance shares made on March 7, 2012; (xviii) fully vested shares totaling 4,712 shares of stock from an initial grant of 15,923 shares of restricted stock and performance shares made on March 25, 2011; and (xix) fully vested shares totaling 22,270 shares of stock from an initial grant of 42,680 shares of restricted stock and performance shares made on December 29, 2008. |
7. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. |
8. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. |
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Vinit K. Asar | 02/16/2022 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |